# Pfizer Inc. (PFE) — Q1-2016 Earnings Results

**Report date:** 2016-05-03 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q1-2016

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Up 2.74%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.67 | N/A | +22.49% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting ongoing strategic initiatives. However, they did not provide specific guidance for future revenue.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> While we did not provide revenue figures, we remain focused on our strategic initiatives.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's strong EPS performance, exceeding expectations by over 22%, has positively impacted investor sentiment, leading to a 2.74% increase in stock price. The lack of revenue figures and guidance suggests some uncertainty, but the positive EPS surprise indicates effective cost management or strong product performance. Investors may view this as a sign of resilience in Pfizer's operations.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q1-2016_